Mylan has been fighting for more than a year to block Teva’s generic EpiPen. But all along EpiPen itself has been classified as a generic drug for Medicaid patients--and now, U.S. senators are calling on the Justice Department to find out why.
The power of a Hillary Clinton tweet showed again Wednesday, when the presidential candidate spoke on drug price, raising fears of government action. Biotech stocks, pharma stocks--even U.K. drugmakers suffered.
Amid a frenzy of criticism for the price of EpiPen, Mylan swiftly expanded its co-pay help for patients. But it did not adjust the actual price of a med that’s more than 400% more expensive than it was in 2009.